Literature DB >> 7542074

Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.

H F Dvorak1, M Detmar, K P Claffey, J A Nagy, L van de Water, D R Senger.   

Abstract

Vascular permeability factor (VPF), also known as vascular endothelial growth factor (VEGF), is a multifunctional cytokine that is overexpressed in many transplantable animal and autochtonous human cancers, in healing wounds, and in chronic inflammatory disorders such as psoriasis and rheumatoid arthritis. All of these entities are characterized by angiogenesis, altered extracellular matrix, and variable degrees of hypoxia. In addition, two VPF/VEGF receptors, flt-1 and kdr, are overexpressed by endothelial cells that line the microvessels that supply these tumors/inflammatory reactions. On the basis of these and other data, we have proposed a model of angiogenesis in which VPF/VEGF plays a central role: this model is applicable to tumors and also to the angiogenesis that occurs in non-neoplastic processes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542074     DOI: 10.1159/000236988

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  71 in total

1.  Novel 14S,21-dihydroxy-docosahexaenoic acid rescues wound healing and associated angiogenesis impaired by acute ethanol intoxication/exposure.

Authors:  Haibin Tian; Yan Lu; Shraddha P Shah; Song Hong
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

2.  A systems approach to hemostasis: 4. How hemostatic thrombi limit the loss of plasma-borne molecules from the microvasculature.

Authors:  John D Welsh; Ryan W Muthard; Timothy J Stalker; Joshua P Taliaferro; Scott L Diamond; Lawrence F Brass
Journal:  Blood       Date:  2016-01-06       Impact factor: 22.113

Review 3.  Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.

Authors:  Lei Miao; C Michael Lin; Leaf Huang
Journal:  J Control Release       Date:  2015-08-12       Impact factor: 9.776

4.  PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.

Authors:  Peter Noy; Hannah Williams; Anyaporn Sawasdichai; Kevin Gaston; Padma-Sheela Jayaraman
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

5.  Structural adaptations in the murine colon microcirculation associated with hapten-induced inflammation.

Authors:  Dino J Ravnic; Moritz A Konerding; Akira Tsuda; Harold T Huss; Tanja Wolloscheck; Juan P Pratt; Steven J Mentzer
Journal:  Gut       Date:  2006-11-17       Impact factor: 23.059

6.  Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer.

Authors:  Peter Büchler; Howard A Reber; Mendel M Roth; Mark Shiroishi; Helmut Friess; Oscar J Hines
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

7.  Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes.

Authors:  Agnieszka Jazwa; Agnieszka Loboda; Slawomir Golda; Jaroslaw Cisowski; Magdalena Szelag; Anna Zagorska; Patrycja Sroczynska; Justyna Drukala; Alicja Jozkowicz; Jozef Dulak
Journal:  Free Radic Biol Med       Date:  2005-12-19       Impact factor: 7.376

Review 8.  Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.

Authors:  Christopher Christophi; Nadia Harun; Theodora Fifis
Journal:  J Gastrointest Surg       Date:  2008-01-08       Impact factor: 3.452

Review 9.  Adhesion molecules in rheumatoid arthritis.

Authors:  N Oppenheimer-Marks; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  1998

10.  Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma.

Authors:  Justin G Wilkes; Brianne R O'Leary; Juan Du; Adrienne R Klinger; Zita A Sibenaller; Claire M Doskey; Katherine N Gibson-Corley; Matthew S Alexander; Susan Tsai; Garry R Buettner; Joseph J Cullen
Journal:  Clin Exp Metastasis       Date:  2018-02-02       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.